drugset / Trial / NCT00935194

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

NCT00935194

Phase 4 Completed 102 enrolled Capital Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Chinese medicinal herbs are effective and safe for treating novel influenza A (H1N1) infection.

Timeline

Start
2009-07
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 75 mg Oral
Subject maxingshigan-yinqiaosan Unknown 200 ml Oral

Indications